Institutional
Venrock Adviser, LLC
CIK 0001615982
$2.68B
Reported AUM
33
Positions
Q1 2026
Period
2026-05-15
Filed
Portfolio · Q1 2026
Top holdings
| # | Stock | Issuer | Price | Day % | 1Y Gr. | 5Y Gr. | Value | % of book | Δ shares (QoQ) | Status |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | APGE | APOGEE THERAPEUTICS INC | $134.09 | -0.16% | 255.38% | 484.81% | $714.9M | 26.68% | — | HELD |
| 2 | ERAS | ERASCA INC | $18.15 | -2.84% | 1243.88% | -21.87% | $265.1M | 9.89% | — | HELD |
| 3 | ORKA | ORUKA THERAPEUTICS INC | $96.51 | -1.38% | 619.56% | 390.71% | $203.5M | 7.60% | — | HELD |
| 4 | SYRE | SPYRE THERAPEUTICS INC | $98.33 | -3.12% | 524.23% | -44.00% | $185.9M | 6.94% | — | HELD |
| 5 | KALV | KALVISTA PHARMACEUTICALS INC | — | — | — | — | $130.3M | 4.86% | — | HELD |
| 6 | DNTH | DIANTHUS THERAPEUTICS INC | $106.92 | -5.08% | 447.06% | 10.00% | $99.0M | 3.70% | — | HELD |
| 7 | DMRA | DAMORA THERAPEUTICS INC | $28.99 | -0.75% | 811.39% | -73.74% | $93.3M | 3.48% | — | HELD |
| 8 | OCUL | OCULAR THERAPEUTIX INC | $8.17 | -3.54% | -31.50% | -22.68% | $87.6M | 3.27% | — | HELD |
| 9 | COGT | COGENT BIOSCIENCES INC | $38.93 | -5.88% | 248.33% | 379.59% | $77.0M | 2.87% | — | HELD |
| 10 | VRDN | VIRIDIAN THERAPEUTICS INC | $18.92 | -4.92% | 14.30% | 48.73% | $75.9M | 2.83% | — | HELD |
| 11 | SVRA | SAVARA INC | $5.46 | -1.44% | 113.90% | 257.42% | $75.0M | 2.80% | — | HELD |
| 12 | ELVN | ENLIVEN THERAPEUTICS INC | $54.81 | 1.59% | 192.63% | 186.06% | $67.7M | 2.53% | — | HELD |
| 13 | ORIC | ORIC PHARMACEUTICALS INC | $11.07 | -4.90% | 15.02% | -47.31% | $54.7M | 2.04% | — | HELD |
| 14 | VOR | VOR BIOPHARMA INC | $21.15 | -2.98% | -51.02% | -93.00% | $54.3M | 2.03% | — | HELD |
| 15 | MAZE | MAZE THERAPEUTICS INC | $26.92 | -2.57% | 85.44% | 125.92% | $47.8M | 1.78% | — | HELD |
| 16 | CTMX | CYTOMX THERAPEUTICS INC | $3.10 | -5.49% | 33.40% | -38.77% | $46.9M | 1.75% | — | HELD |
| 17 | JBIO | JADE BIOSCIENCES INC | $19.75 | -1.25% | 190.28% | -96.57% | $45.2M | 1.69% | — | HELD |
| 18 | DYN | DYNE THERAPEUTICS INC | $25.18 | -2.14% | 150.55% | 48.73% | $39.4M | 1.47% | — | HELD |
| 19 | CBIO | CRESCENT BIOPHARMA INC. | $14.47 | -3.66% | 25.17% | -106.15% | $39.2M | 1.46% | — | HELD |
| 20 | ZURA | ZURA BIO LTD | $5.43 | -1.99% | 260.00% | -20.70% | $38.3M | 1.43% | — | HELD |
| 21 | RLMD | RELMADA THERAPEUTICS INC | $5.31 | -0.75% | 800.00% | -77.79% | $33.7M | 1.26% | — | HELD |
| 22 | — | ENGENE HOLDINGS INC | — | — | — | — | $32.5M | 1.21% | — | HELD |
| 23 | TENX | TENAX THERAPEUTICS INC | $13.70 | -9.27% | 142.77% | -99.41% | $26.8M | 1.00% | — | HELD |
| 24 | ANL | ADLAI NORTYE LTD | $13.00 | 0.00% | 796.55% | 61.49% | $22.2M | 0.83% | — | HELD |
| 25 | IPSC | CENTURY THERAPEUTICS INC | $2.02 | -7.76% | 311.65% | -91.17% | $19.7M | 0.73% | — | HELD |
| 26 | CGEM | CULLINAN THERAPEUTICS INC | $16.50 | -5.82% | 115.25% | -41.50% | $19.6M | 0.73% | — | HELD |
| 27 | HELP | CYBIN INC | $7.82 | -3.93% | 3.44% | -92.65% | $18.5M | 0.69% | — | HELD |
| 28 | SRZN | SURROZEN INC | $22.21 | 6.63% | 101.91% | -80.97% | $18.4M | 0.69% | — | HELD |
| 29 | SEPN | SEPTERNA INC | $34.45 | -2.08% | 182.15% | 36.22% | $12.2M | 0.45% | — | HELD |
| 30 | KRRO | KORRO BIO INC | $10.37 | -0.77% | -24.55% | -97.29% | $11.4M | 0.43% | — | HELD |
| 31 | ANRO | ALTO NEUROSCIENCE INC | $27.07 | -5.45% | — | — | $11.2M | 0.42% | — | HELD |
| 32 | ARTV | ARTIVA BIOTHERAPEUTICS INC | $10.10 | -3.16% | — | — | $10.4M | 0.39% | — | HELD |
| 33 | XFOR | X4 PHARMACEUTICALS INC | $3.98 | -0.50% | — | — | $1.4M | 0.05% | — | HELD |
Source: SEC EDGAR · accession 0001615982-26-000011. 13F discloses long positions only — shorts, foreign equities, and options are excluded.